• Return to Headlines

Stemline Therape Falls 4.82% on Heavy Volume: Watch For Potential Rebound

By Shiri Gupta

Stemline Therape (NASDAQ:STML) traded in a range yesterday that spanned from a low of $9.65 to a high of $10.23. Yesterday, the shares fell 4.8%, which took the trading range below the 3-day low of $9.98 on volume of 58,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

Stemline Therape share prices have moved between a 52-week high of $20.55 and a 52-week low of $9.98 and are now trading 2% above that low price at $10.17 per share. Over the last five market days, the 200-day moving average (MA) has gone down 0.5% while the 50-day MA has declined 2.7%.

SmarTrend recommended that its subscribers protect gains by selling shares of Stemline Therape on October 15th, 2018 by issuing a Downtrend alert when the shares were trading at $14.75. Since that call, shares of Stemline Therape have fallen 31.1%. We are now looking for when a new Uptrend will commence and will alert SmarTrend subscribers in real time.

Keywords: rebounders stemline therape

Ticker(s): STML